INTRODUCTION {#SEC1}
============

Human flap endonuclease 1 (hFEN1) plays a key role in maintaining genomic stability by accurately processing DNA intermediates during replication and repair ([@B1]). Impaired DNA replication and repair due to hFEN1 deficiency is the underlying cause of many diseases including cancer ([@B2]). In addition to its flap endonuclease (FEN) activity, hFEN1 also exhibits relatively low levels of exonuclease (EXO) and gap endonuclease (GEN) activities ([@B3]). The primary FEN activity of hFEN1, incising 5′ flaps at the single- and double-stranded DNA (ss-dsDNA) junction, is essential for Okazaki fragment maturation ([@B4],[@B5]), long-patch base excision repair ([@B6]), and telomere leading-strand synthesis ([@B7],[@B8]). The GEN activity of hFEN1, which potentially generates substrates for the recombination repair pathway, is important for processing stalled DNA replication forks ([@B9],[@B10]).

Because nucleases digest DNA, FEN1 nuclease activity must be tightly controlled to ensure that it functions at the appropriate time and subcellular location. To date, at least three mechanisms have been proposed to regulate FEN1: precise substrate selection, protein--protein interactions and posttranslational modifications (PTMs). As a representative member of the 5′ structure-specific nuclease superfamily, FEN1 preferentially binds to sequence-independent double-flap DNA substrates, which contain both a 3′ and a 5′ flaps. The 1-nucleotide (nt) 3′ flap is first recognized by FEN1, leading to ∼100° bending of the DNA at the ss-dsDNA junction. Different models of 5′ flap recognition have been proposed. Recent biochemical and structural studies suggest that the inverted 5′ flap threads into the active site of hFEN1 via 'phosphate steering' guided by residues in its gateway and cap regions (α4 and α5) ([@B11]), which undergo a disorder-to-order transition upon substrate DNA binding.

FEN1 interacts with a number of proteins, including proliferating cell nuclear antigen (PCNA) ([@B12],[@B13]), Werner syndrome helicase (WRN) ([@B14],[@B15]), Rad9--Rad1--Hus1 (9--1--1) complex ([@B16],[@B17]), and WDR4 (also known as WUHO) ([@B18]). These protein--protein interactions not only direct hFEN1 toward distinct DNA replication and repair substrates/pathways but also control the balance between its FEN and GEN activities. PCNA recruits FEN1 to the DNA replication fork and stimulates FEN activity, which is critical for RNA primer removal ([@B4]). WRN stimulates both the FEN and GEN activities of FEN1 in coordination with PCNA ([@B19]). The 9--1--1 complex serves as a platform for DNA repair and enhances the FEN and GEN activities of FEN1 *in vitro* ([@B20]). More recently, it was demonstrated that WDR4 stimulates FEN activity and represses GEN activity ([@B18]).

hFEN1 undergoes multiple types of PTMs, including phosphorylation ([@B21]), methylation ([@B22]), acetylation ([@B23],[@B24]), SUMOylation ([@B25]), ubiquitination ([@B25]) and succinylation ([@B26]). Of these PTMs, phosphorylation and methylation have been shown to antagonistically regulate hFEN1 activity ([@B22]). Phosphorylation of hFEN1 at Ser187 by cycle-dependent kinases reduces nuclease activity and PCNA binding and stimulates SUMOylation, ubiquitination, and proteasomal degradation ([@B25]). However, methylation of hFEN1 at Arg192 by the PRMT5 arginine methyltransferase strongly suppresses hFEN1 phosphorylation, which enhances interaction with PCNA ([@B22]).

Full length of hFEN1 has been co-crystallized with PCNA ([@B13]). Additional structural and biochemical analyses of FEN1 proteins have revealed elegant FEN1 regulatory mechanisms involving dsDNA bending, 3′ flap recognition, 5′ flap threading, and catalysis ([@B27]). However, the molecular basis for 5′ flap capture prior to threading remains unclear. We report here the crystal structures of pre-threading and mutant (R192F) hFEN1--DNA complexes, which represent the complex before 5′ flap binding and after methylation, respectively. These structures, together with mutagenesis and biochemical studies, provide mechanistic insights into 5′ flap recognition by and the protein--protein interactions of hFEN1.

MATERIALS AND METHODS {#SEC2}
=====================

Protein expression and purification {#SEC2-1}
-----------------------------------

Full-length and C-terminally truncated hFEN1 (residues 1--380 and 1--333, respectively) were amplified by PCR and cloned into a modified pET28b expression vector, which contains a C-terminal 6× His-tag. Site-directed mutagenesis was performed with the QuickChangeTM Site-Directed Mutagenesis Kit from Stratagene (La Jolla, CA, USA), as previously described ([@B34]). Primers used for cloning and mutagenesis are listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}.

All hFEN1 proteins were expressed and purified as previously described ([@B22]). Briefly, transformed *Escherichia coli* strain BL21 (DE3) clones were grown at 37°C in LB medium containing 50 μg/ml Kanamycin to OD~600~ of 0.6--0.8. Protein expression was induced by adding isopropyl-β-[d]{.smallcaps}-thioga-lactopyranoside (IPTG) to a final concentration of 0.4 mM at 16°C for 16 h. Cells were resuspended in lysis buffer (20 mM Tris (pH 7.8), 1 M NaCl, 5% glycerol, 3 mM β-ME, and 10 mM imidazole) after harvesting, lysed by sonication, and centrifuged at 18 000 × *g* for 45 min at 4°C. The supernatant was purified through a HisTrap HP column (GE Healthcare), equilibrated with buffer A (20 mM Tris \[pH 7.8\], 1 M NaCl, 5% \[w/v\] glycerol, and 10 mM imidazole), washed with 60 mM imidazole, and eluted with 300 mM imidazole. After desalting, the protein was loaded onto a HiTrap Q column (GE Healthcare) pre-equilibrated with buffer B (20 mM Tris \[pH 7.8\], 100 mM KCl, 5% \[w/v\] glycerol and 1 mM DTT). Fractions containing hFEN1 proteins were eluted with a linear gradient from 100 to 1000 mM KCl. The protein was finally purified through a Superdex 75 10/300 column (GE Healthcare) with buffer C (20 mM Tris \[pH 7.8\], 100 mM KCl, 0.1 mM EDTA, and 1 mM DTT) and stored at −80°C.

Crystallization and structure determination {#SEC2-2}
-------------------------------------------

Crystallization was performed using the sitting drop vapor diffusion method at 293 K. Freshly purified C-terminally truncated hFEN1 at a concentration of ∼15 mg/ml was centrifuged to remove the insoluble fraction before crystallization. The hFEN1--DNA binary complex was prepared by mixing hFEN1 and double-flap DNA at a 1:1.5 molar ratio and a concentration of ∼5 mg/ml. After screening and optimization of the length and sequence context of double-flap DNA, crystals were grown in 35--40% (w/v) PEG 3350, 20 mM Tris (pH 7.8), 100 mM KCl and 10 mM MgCl~2~. Cryo-cooling was performed as previously described ([@B35]). Diffraction intensities were collected on the BL17U beamline at the Shanghai Synchrotron Radiation Facility (Shanghai, China) and were integrated and scaled using the X-ray Detector Software (XDS) suite ([@B36]). The structures were determined by molecular replacement using a published hFEN1 structure (PDB ID: 3Q8K) ([@B30]) as the search model. Structures were refined using PHENIX ([@B37]) and interspersed with manual model building using COOT ([@B38]). The refined models contained one hFEN1 in the asymmetric unit. The statistics for data collection and refinement are listed in Table [1](#tbl1){ref-type="table"}. All residues are in the most favorable allowed regions of the Ramachandran plot. All structural figures were rendered in PyMol ([www.pymol.org](http://www.pymol.org)). The primer sequences used for crystallization are listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}.

###### 

Statistics from crystallographic analysis

                            Apo-protein             Pre-threading           Pre-threading           Product
  ------------------------- ----------------------- ----------------------- ----------------------- ----------------------
  **Data collection**                                                                               
  Space group               *P*2~1~2~1~2~1~         *P*2~1~2~1~2~1~         *P*2~1~2~1~2~1~         *C*222~1~
  Cell dimensions                                                                                   
   *a, b, c* (Å)            40.95, 61.07, 110.45    48.07, 93.83, 103.02    47.67, 92.73, 102.78    88.31, 244.76, 70.91
   *α, β, γ* (°)            90, 90, 90              90, 90, 90              90, 90, 90              90, 90, 90
  Resolution (Å)            30--1.90 (1.95--1.90)   30--1.95 (2.00--1.95)   30--2.25 (2.31--2.25)   30--2.3 (2.36--2.30)
  *R* ~merge~               9.3 (61.3)              3.3 (37.0)              9.1 (57.9)              7.1 (71.3)
  *I/σ(I)*                  13.8 (2.8)              23.7 (2.8)              11.1 (2.1)              16.1 (2.5)
  Completeness (%)          99.9 (100.0)            98.0 (87.8)             98.8 (93.1)             98.8 (90.7)
  Redundancy                5.9 (5.3)               4.6 (3.1)               5.7 (3.8)               5.1 (5.1)
  **Refinement**                                                                                    
  Resolution (Å)            30-1.9                  30-1.95                 30-2.25                 30-2.3
  No. reflections           24041                   33589                   22086                   34301
  *R* ~work~/*R*~free~      19.7/22.6               21.5/22.7               23.5/26.9               20.9/23.1
  No. atoms                                                                                         
   Protein/DNA              2036/--                 2290/806                2290/806                2483/791
   Ion                      6                       1                       1                       --
   Water                    162                     175                     10                      85
  *B* factors                                                                                       
   Protein/DNA              29.25/--                44.05/57.50             52.54/67.83             55.76/88.93
   Ion                      46.67                   128.80                  133.83                  --
   Water                    32.22                   46.38                   52.82                   43.51
  RMSD                                                                                              
   Bond length (Å)          0.005                   0.005                   0.009                   0.008
   Bond angle (°)           0.732                   0.675                   0.968                   0.850
  Ramachandran statistics                                                                           
   Favored (%)              98.03                   98.60                   97.50                   97.76
   Allowed (%)              1.97                    1.40                    2.50                    2.24
   Outliers (%)             0                       0                       0                       0

Values in parentheses refer to the highest resolution shell.

*R* ~factor~ = Σ\|\|*F*(obs) -- *F*(calc)\|\|/Σ\|*F*(obs)\|.

*R* ~free~ = *R* factor calculated using 5.0% of the reflection data randomly chosen and omitted from the start of refinement.

RMSD = root-mean-square deviation.

Nuclease assays {#SEC2-3}
---------------

Full-length hFEN1 proteins were used for nuclease assays. GEN activity and steady-state *K*~m~ and *K*~cat~ measurements were obtained using gapped and double-flap DNA substrates listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. All oligonucleotides were purchased from Sangon (Shanghai) with either 3′- or 5′-ends labeled with 6-carboxfluorescein (6-FAM). For the GEN reaction, typically 1000--5000 nM hFEN1 were incubated with 1000 nM DNA in a 10 μl reaction volume containing 20 mM Tris (pH 7.5), 100 mM KCl, 5 mM NaCl~2~, 0.1 mg/ml BSA, 1 mM EDTA and 7 mM MgCl~2~. Reactions were carried out at 37°C for 30 min and terminated by the addition of formamide loading buffer (1 mM EDTA and 80% deionized formamide). After denaturation by heating at 95°C for 10 min, reaction products were resolved on 20% polyacrylamide sequencing gels containing 7 M urea. To measure the steady-state parameters, typically 0.05--16 nM hFEN1 was incubated with 25--1000 nM double-flap DNA for 10 minutes under the same conditions as the GEN reaction. All reactions were independently repeated at least six times. Quantification and curve fitting were carried out as previously described ([@B29],[@B39]).

Cell culture and western blot analysis {#SEC2-4}
--------------------------------------

To isolate HeLa cell lines stably-expressing hFEN1 proteins, cells were cultured in DMEM supplemented with 10% FBS and were transfected with pEZ-M12-ef1α-3 × Flag plasmids containing full-length wild-type, K200A, K201A, K200/201A or R192F hFEN1. Stable cell lines were established by G418 selection and verified by immunofluorescence staining with an anti-FLAG antibody. About 4 × 10^6^ cells were collected and lysed with RIPA Lysis Buffer (Beyotime, CH) containing a protease inhibitor cocktail (Roche, CH). Whole-cell extracts were subjected to immunoprecipitation with anti-FLAG M2 magnetic beads (Sigma, USA), and cell extracts or immunoprecipitates were resolved by SDS-PAGE followed by electrotransfer onto PVDF membranes and incubation with primary (1:1000 dilution, Abcam, GB) and secondary (1:2000 dilution, Ptg lab, USA) antibodies sequentially after blocking. The membranes were further washed with TBST and developed using ECL reagents (Pierce, MA, USA).

Cell cycle synchronization {#SEC2-5}
--------------------------

HeLa cell lines were synchronized in mid S phase using a double-thymidine block method in which cells were treated with 2.5 mM thymidine (Sigma, USA) for 15 h, released for 8 h in thymidine-free medium, and treated with 2.5 mM thymidine again for another 18 h, followed by 3 h of release in thymidine-free medium before cell collection.

RESULTS {#SEC3}
=======

Overall structure and catalytic center configuration of hFEN1 nuclease {#SEC3-1}
----------------------------------------------------------------------

To investigate the mechanisms by which hFEN1 is regulated, we generated wild-type, D181A, R192F, and D181A/R192F mutant hFEN1 proteins for co-crystallization with a double-flap DNA substrate. It is known that the C-terminus of FEN1 is structurally disordered, which makes crystallization difficult. Therefore, for crystallization, we used C-terminally truncated wild-type and mutant hFEN1 (residues 1--333; [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}), which contain the entire catalytic site and are expected to be fully competent for catalysis ([@B20],[@B30]). We chose to investigate the D181A mutation because among mutations to conserved amino acids in FEN1, it was found to reduce hFEN1 cleavage activity to the greatest extent ([@B40]). Our previous study ([@B22]) and studies by other groups ([@B41],[@B42]) have demonstrated that substitution of arginine residues with phenylalanine residues can mimic arginine methylation for biochemical characterization. Therefore, we replaced the primary methylation site Arg192 of hFEN1 with phenylalanine. Although phenylalanine does not perfectly mimic methylation of the arginine residue, both methylation and substitution with phenylalanine increase protein hydrophobicity. Furthermore, we found previously that R192F hFEN1 has a phosphorylation pattern and PCNA binding activity similar to those of methylated hFEN1 *in vitro* and in cells ([@B22]). The crystals were grown in the presence of Mg^2+^ ions and diffracted X-rays to 1.9--2.3 Å resolution (Table [1](#tbl1){ref-type="table"}). Wild-type hFEN1 was crystallized in the apo-form, and the structures of two types of hFEN1--DNA complexes were obtained (Figure [1a](#F1){ref-type="fig"} and [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). The intact 5′ flap was observed in both the D181A and D181A/R192F hFEN1--DNA structures in which the --1 and +1 bases (relative to the 5′ and 3′ side of the scissile phosphate) remained base-paired with the DNA template strand (Figure [1A](#F1){ref-type="fig"} and [Supplementary Figure S2B, C](#sup1){ref-type="supplementary-material"}). Therefore, we consider these to be 'pre-threading' structures. In the R192F hFEN1--DNA structure, which represents the cleaved product complex, the 5′ flap strand was cleaved but not engaged with the active site (Figure [1A](#F1){ref-type="fig"}, [B](#F1){ref-type="fig"} and [Supplementary Figure S2D](#sup1){ref-type="supplementary-material"}).

![Overall structural comparison of the hFEN1 nuclease core domain. (**A**) Superposition of D181A/R192F and R192F hFEN1--DNA structures. A schematic of the DNA substrate used for crystallization is shown on top with colors corresponding to those in the structures below. The hFEN1 protein is colored in white with gateway and cap helices (α2, α3 and α4) labeled and shown in blue. The β-pin region is colored red. The DNA template strand in the D181A/R192F hFEN1--DNA (pre-threading) structure is drawn in orange with the 3′ and 5′ flap strands in pink and yellow, respectively. The part of the 5′ flap to be cleaved in the product structure is in magenta. The DNA in the R192F hFEN1--DNA (product) structure is drawn in green. (**B**) Superposition of two hFEN1 product complexes. The hFEN1--DNA product structure solved in the current study has the same coloring as in A. The published hFEN1 product structure (PDB ID: 3Q8K) is colored in yellow with DNA in magenta and cap helices α4 and α5 in cyan. (**C**) Superposition of the active site of the hFEN1 apo-protein structure (green) and product structure (white). The catalytic residues and 5′ flap end (yellow) are labeled and shown as sticks. Two metal ions (A and B) and six coordinating water molecules (red) in the apo-protein structure are shown as spheres.](gky911fig1){#F1}

The overall conformation of these hFEN1 structures can be virtually superimposed onto the previously solved hFEN1 threading structure (Protein Data Bank \[PDB\] ID: 5UM9). The gateway and cap helices α2, α4 and α5 are completely disordered in the hFEN1 apo-protein structure ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). In all three hFEN1--DNA structures, however, the α2 helix becomes ordered upon interaction with the substrate DNA, which induces the DNA duplex to bend sharply at approximately 100° (Figure [1A](#F1){ref-type="fig"}, [B](#F1){ref-type="fig"} and [Supplementary Figure S2B--D](#sup1){ref-type="supplementary-material"}). We also observed that the partially structured α4 helix in the R192F hFEN1--DNA product complex is shifted away from the active site compared to that in the published product structure (PDB ID: 3Q8K; Figure [1B](#F1){ref-type="fig"} and [Supplementary Figure S2D](#sup1){ref-type="supplementary-material"}). However, the cap region (part of the α4 and α5 helices; [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}) is disordered in all four structures solved in this study ([Supplementary Figure S2B--D](#sup1){ref-type="supplementary-material"}). These observations are consistent with the disorder-to-order transition of hFEN1 upon dsDNA binding.

Despite their nearly identical protein conformations, only the active site of the hFEN1 apo-protein structure but not of the hFEN1--DNA structures contained an electron density corresponding to the catalytic metal ions, which were positioned 4 Å apart (Figure [1C](#F1){ref-type="fig"} and [Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). These two metal ions are coordinated by seven conserved acidic hFEN1 residues and water molecules (Figure [1C](#F1){ref-type="fig"} and [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). The A site metal ion, in its hexa-aquated form, is coordinated by Asp34, Asp86, Glu158 and Glu160, whereas the B site metal ion is coordinated by Asp179, Asp181 and Asp 233. The overall configuration and these catalytic residues align well with that of hFEN1 in complex with the inhibitor *N-*hydroxyurea (PDB ID: 5FV7; [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). Compared to that in the hFEN1 product structure, β7 in the hFEN1 apo-protein structure is shifted toward the active site, and Glu160 undergoes substantial rotamer change upon metal coordination (Figure [1C](#F1){ref-type="fig"}).

Pre-threading hFEN1--DNA complexes: substrate interactions and functional implications {#SEC3-2}
--------------------------------------------------------------------------------------

hFEN1 and the upstream DNA containing the 3′ flap could be adequately superimposed in all the hFEN1--DNA structures (Figure [1A](#F1){ref-type="fig"}). However, the downstream DNA in both the D181A and D181A/R192F hFEN1--DNA structures is shifted away from the active site compared with that in the published threading structure, which contains a 5′ flap threaded through the helical gateway/cap (PDB ID: 5UM9; Figure [2A](#F2){ref-type="fig"}, B). Clear electron density of the unthreaded 5′ flap was observed in the D181A and D181A/R192F hFEN1--DNA structures, because it lies outside the active site, occupying nearly the same space as the α5 helix observed in the hFEN1 threading structure (Figure [2B](#F2){ref-type="fig"} and [Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}). The distance between the scissile phosphate and the active site divalent metals is \>16 Å in these two structures.

![Pre-threading structure of the hFEN1--DNA complex. (**A**) Superposition of double-flap DNA in the hFEN1 pre-threading structure (colored) and the published threading structure (white, PDB ID: 5UM9). The protein is represented by the green surface, and the α2 helix is shown in blue. The template strand, 5′ flap, 3′ flap, gateway/cap, and H2TH binding site are labeled. The black arrowhead indicates the DNA shift between the threading and pre-threading structures. (**B**) Superposition of the hFEN1 pre-threading structure (green) and threading structure (white, PDB ID: 5UM9). The unthreaded 5′ flap in the pre-threading structure is colored yellow. The gateway and cap helices (α4 and α5) in the threading structure are in blue. (**C**) Interactions between hFEN1 and the unthreaded 5′ flap in the D181A hFEN1--DNA pre-threading structure. Helices, loops, and nucleotide bases of the 5′ flap are labeled. Protein side chains involved in the protein-5′ flap interactions are shown as sticks.](gky911fig2){#F2}

The downstream dsDNA in our pre-threading structures is anchored to the helix-2turn-helix (H2TH) motif, as observed in all the hFEN1--DNA structures (Figure [2A](#F2){ref-type="fig"}, B). The α2 helix and two loops (α2--α3 and α5--α6) interact with the unthreaded 5′ flap through hydrogen bonds, stacking interactions, and van der Waals interactions (Figure [2C](#F2){ref-type="fig"} and [Supplementary Figure S4A, B](#sup1){ref-type="supplementary-material"}). As noted above, in the hFEN1 pre-threading structures, the +1 and --1 bases of the 5′ flap remain base-paired. The +2 base makes contact with the α2--α3 loop, and the +3 base is inserted between the +1 base-pair and the α2 helix. Arg47 at the end of the α2 helix interacts with the +3 nucleoside, and the +4 base is held in place by four side chain residues: Tyr40, Ile44, Leu130 and Val131.

Two residues, Tyr40 and Arg47, have been reported to play multiple roles in hFEN1 cleavage ([@B11],[@B30]). Tyr40, at the entrance of the active site, stabilizes the ordered helical gateway and packs against either the +1 or --1 base during cleavage ([Supplementary Figure S4b,c](#sup1){ref-type="supplementary-material"}). In the pre-threading structures, Tyr40 adopts a rotamer conformation similar to that in the published hFEN1--DNA product complex (PDB ID: 5K97; [Supplementary Figure S4b](#sup1){ref-type="supplementary-material"}). Arg47, on the other side, forms a salt bridge with the phosphate group and a stacking interaction with the sugar pucker of the +3 nucleoside (Figure [2c](#F2){ref-type="fig"} and [Supplementary Figure S4b](#sup1){ref-type="supplementary-material"}). To further confirm the interactions between Arg47 and the 5′ flap, we replaced Arg47 with lysine, which has an amino group that mimics the electrostatic interaction and hydrogen-bonding ability of Arg but has substantially reduced stacking interaction potential. We measured the *K*~m~ and *K*~cat~ of double-flap DNA cleavage by the R47K mutant hFEN1. The *K*~m~ of R47K was 4-fold greater than that of wild-type hFEN1, and the *K*~cat~ was approximately 8-fold lower than that of the wild-type hFEN1, resulting in 30-fold lower overall efficiency (*K*~cat~/*K*~m~; [Supplementary Table S2](#sup1){ref-type="supplementary-material"}).

Loop-to-helix transition of the β-pin region that potentiates the FEN activity for RNA primer removal {#SEC3-3}
-----------------------------------------------------------------------------------------------------

Bending of the duplex DNA at the ss-dsDNA junction is an essential event prior to 5′ flap threading by hFEN1. In addition to the helical gateway and cap helices, the β-pin region between β8 and β9 (residues 194--200, LTASEAK) interacts with the dsDNA at the bending point, as previously observed (Figure [1A](#F1){ref-type="fig"} and [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}) ([@B30]). In the wild-type and D181A hFEN1--DNA structures, the β-pin region adopts a loop conformation, as observed in all crystallized hFEN1 to date ([Supplementary Figures S2a, b and S5a](#sup1){ref-type="supplementary-material"}). Unexpectedly, this β-pin region is rigidified into a short helix in both D181A/R192F and R192F hFEN1--DNA structures, which contain a point mutation at the primary methylation site of hFEN1 (Figure [3A](#F3){ref-type="fig"} and [Supplementary Figure S2C, D](#sup1){ref-type="supplementary-material"}). However, this conformational change does not alter the position of β8 and β9 in any of the hFEN1 structures solved in this study ([Supplementary Figure S5B](#sup1){ref-type="supplementary-material"}).

![Loop-to-helix transition of the β-pin region in the R192F hFEN1--DNA structure. (**A**) The electron densities of phenylalanine at the 192 position and of the β-pin helix are shown in grey with the refined 2Fo-Fc map contoured at 1σ. (**B**) Interactions between the β-pin and DNA in D181A (left) and D181A/R192F (right) hFEN1--DNA structures. The β-pin region adopting a loop or helix conformation is colored red. The yellow dashed lines indicate interactions between lysine residues and DNA through a water molecule (red sphere). (**C**) Denaturing PAGE gel showing reduced GEN activity of the R192F mutant compared to wild-type (WT) hFEN1. 3′-fluorescence-labeled gapped DNA (1 μM) was incubated with 1, 2, 3, 4 or 5 μM of R192F or WT hFEN1 proteins in the presence of Mg^2+^. M indicates the DNA markers. (**D**) Quantification of GEN product cleavage by WT and mutant hFEN1 proteins.](gky911fig3){#F3}

The transition from the loop conformation to the helix conformation was only observed when arginine was replaced by phenylalanine. Why is this so? In the pre-threading D181A hFEN1--DNA structure, Arg192 (located at the end of β8) interacts with the --3 phosphate group through a water molecule (Figure [3b](#F3){ref-type="fig"}, left panel). Moreover, Arg192 is surrounded by three nonpolar residues (Met180, Leu190, and Phe207) and forms an aromatic π-interaction with His193. Phenylalanine substitution of arginine increases hydrophobicity at the 192 position, favoring the loop-to-helix transition. Indeed, in both the R192F and D181A/R192F hFEN1--DNA structures, His193 shows clear movement toward the DNA minor groove due to the favorable aromatic interactions between the phenylalanine and surrounding residues (Figure [3B](#F3){ref-type="fig"} and [Supplementary Figure S5C](#sup1){ref-type="supplementary-material"}), which further stabilize the helical conformation of the β-pin region. Leu202, however, shifts \>4 Å in the opposite direction because its interaction with His193 is lost ([Supplementary Figure S5C](#sup1){ref-type="supplementary-material"}).

Steady-state kinetic parameters were measured using full-length hFEN1 to complement our structural observation of the β-pin helix formation. Three residues, Arg192, Lys200 and Lys201, were mutated based on the D181A/R192F hFEN1--DNA structure (Figure [3B](#F3){ref-type="fig"}). The R192F mutant exhibited approximately 5-fold lower FEN activity relative to wild-type hFEN1 ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}), which was consistent with the interaction between Arg192 and downstream dsDNA (Figure [3B](#F3){ref-type="fig"}). Surprisingly, the GEN activity of the R192F mutant was almost eliminated, resulting in only a 1-nt EXO product at high hFEN1 concentrations (Figure [3C](#F3){ref-type="fig"}, [D](#F3){ref-type="fig"} and [Supplementary Figure S6](#sup1){ref-type="supplementary-material"}). Kinetic analysis revealed that the *K*~cat~*/K*~m~ for the GEN activity of WT FEN1 was 0.015 μM^−1^ min^−1^ ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). However, we could not determine the *K*~cat~/*K*~m~ of R192F because the GEN product of R192F was not detected. Thus, the R192F mutation appears to favor the FEN activity of hFEN1 over its GEN activity. In the D181A hFEN1--DNA structure, two positively charged residues located at the end of the β-pin, Lys200 and Lys201, interact with the +3 phosphate group of the template strand and upstream DNA, respectively (Figure [3B](#F3){ref-type="fig"}). In the D181A/R192F hFEN1--DNA structure, a salt bridge between Lys200 and the +2 position phosphate of the template strand is maintained. Therefore, alanine substitution of Lys200 impaired the FEN and GEN activity of hFEN1 by 125- and 8-fold ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Lys201, however, shifts away from the upstream DNA in the D181A/R192F hFEN1--DNA structure, and their interaction is lost (Figure [3B](#F3){ref-type="fig"}, right panel). Thus, replacing Lys201 with alanine had little effect on its FEN and GEN activities (Figure [3C](#F3){ref-type="fig"}, [D](#F3){ref-type="fig"} and [Supplementary Table S2](#sup1){ref-type="supplementary-material"}).

The β-pin region is a key motif involved in protein/protein interactions that direct FEN1 toward DNA replication or repair pathways {#SEC3-4}
-----------------------------------------------------------------------------------------------------------------------------------

Because the β-pin region is solvent-exposed in the hFEN1 apo-protein structure, we suspected that it might be involved in protein--protein interactions. The interactions between hFEN1 and partner proteins are essential to ensure precise and accurate incision at the correct location. The antiparallel β-β interactions between hFEN1 and PCNA were observed in the previously solved hFEN1--PCNA structure ([@B13]). In addition, several residues in the hFEN1 core domain (β1 and η2; [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}) interact directly with the PCNA molecule. To further investigate the hFEN1--PCNA interactions, we modeled the interaction between methylated hFEN1 and PCNA based on the superposition of our D181A/R192F hFEN1--DNA structure and the published hFEN1--PCNA complex (PDB ID: 1UL1; Figure [4A](#F4){ref-type="fig"}). According to our model, the helical β-pin is located next to the η2 helix, which is a key element at the interface between hFEN1 and PCNA. Thus, the transition of the β-pin loop into a helix might constrain the protein--protein interface, facilitating hFEN1--PCNA binding.

![Interactions between hFEN1 and partner proteins. (**A**) Methylated hFEN1--PCNA model. hFEN1 and PCNA in the published hFEN1--PCNA structure (PDB ID: 1UL1) are shown in blue and wheat, respectively. The helices and β-sheets located at the R192F hFEN1--PCNA interface are also illustrated. The β-pin region is shown in red, and β1 and the η2 helix are in magenta. The position of the hFEN1 phosphorylation site (Ser197) is indicated in green. (**B**) Comparison of the protein interaction abilities of R192F and wild-type (WT) hFEN1. M2-beads were incubated with cell lysate to immunoprecipitate hFEN1 with its complex. The phosphorylation level of hFEN1 and its binding ability with the indicated proteins was evaluated by western blot analysis. (**C**) Cellular effects of alanine mutations at two β-pin residues of hFEN1. Immunoprecipitation and western blot analysis were conducted, as described for panel (B). Values are means ± S.D. of three independent assays. *P* values (\*\<0.05, \*\*\<0.01) were calculated using Student\'s *t*-tests.](gky911fig4){#F4}

To further examine hFEN1 protein--protein interactions, we established stable cell lines individually expressing full-length 3× Flag-tagged wild-type, R192F, K200A, K201A and K200/K201A hFEN1s and performed co-immunoprecipitation assays (Figure [4B](#F4){ref-type="fig"}, [C](#F4){ref-type="fig"} and [Supplementary Figure S7](#sup1){ref-type="supplementary-material"}). As expected, R192F hFEN1 exhibited less than 25% phosphorylation and slightly but significantly enhanced PCNA binding affinity compared to the wild-type protein (Figure [4B](#F4){ref-type="fig"}). Interactions with CDK2 and Cyclin E were also 40% and 70% lower, respectively, for R192F versus wild-type hFEN1. The CDK2/Cyclin E complex catalyzes FEN1 S187 phosphorylation. Therefore, reduced hFEN1 phosphorylation is likely due to impaired interactions with these kinases. (Figure [4B](#F4){ref-type="fig"}). Consistent with this supposition, alanine substitution of Lys200 and Lys201 reduced both CDK2 and Cyclin E binding to various degrees, which in turn diminished hFEN1 phosphorylation (Figure [4C](#F4){ref-type="fig"}). In addition to moderately decreased PCNA interactions, K200A and K201A mutants both lost the ability to bind Rad1 by ∼40% compared to wild-type. The K200A mutant had ∼60% lower hFEN1-WDR4 interactions compared to wild-type, whereas the K201A mutant showed enhanced WDR4 binding affinity. These results are consistent with *in vitro* analyses of the interactions of purified His-tagged hFEN1 proteins with proteins in HeLa cell lysates ([Supplementary Figure S8](#sup1){ref-type="supplementary-material"}).

DISCUSSION {#SEC4}
==========

hFEN1 is an essential nuclease that maintains genome stability and plays a critical role in DNA replication and repair. Defects in hFEN1 that compromise its protein function are unequivocally associated with cancer ([@B6],[@B43]). Because FEN1 is a structure-specific nuclease, proper 5′ flap DNA binding is key for accurate cleavage. Previous studies show that despite little overall structural change, the gateway and cap (α2, α4 and α5) regions of hFEN1 undergo disorder-to-order transitions upon substrate DNA binding ([@B11],[@B28],[@B30]). In this study, we found that these helices are completely disordered in the DNA-free hFEN1 protein ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). The ordered α2 helix is bound to the 3′ flap in both pre-threading structures of hFEN1. The α4 helix becomes partially structured, but the cap region, including the α5 helix, remains disordered in the hFEN1 product complex. Notably, the cap region is ordered in all published structures of hFEN1 threading and product complexes containing catalytic metals in the active site ([@B11],[@B30]). However, no metal ion could be located in the active site of our hFEN1 product complex, indicating that a well-formed active site containing catalytic metals may be required for the disorder-to-order transition of the cap region. Furthermore, two Mg^2+^ ions, which have been proposed to be critical for interactions between FEN1 and its inhibitor *N-*hydroxyurea ([@B44]), were observed in the active site of the hFEN1 apo-protein structure (Figure [1C](#F1){ref-type="fig"}). Binding of the inhibitor was found to disturb the active site formation by not only changing the position of the metals but also increasing the distance between the two Mg^2+^ ions relative to their positions in the apo-protein structure ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). Thus, we consider it plausible that inhibitor binding could destabilize the active site and preclude the disorder-to-order transition of the cap region, further suppressing cleavage.

The intact 5′ flap was directed away from the active site in both pre-threading structures, which represent the hFEN1--DNA complex before 5′ flap binding (Figure [2A](#F2){ref-type="fig"}). Like other structure-specific nucleases, hFEN1 must meet several conditions prior to cleavage to ensure the specific incision of the flapped DNA substrate. In contrast to other endonucleases that form continuous DNA-binding surfaces, hFEN1 interacts with DNA mainly at the downstream dsDNA and the active site, resulting in severe DNA bending. Despite the shifted DNA after bending, these two DNA-binding sites remain in the pre-threading structures (Figure [2A](#F2){ref-type="fig"} and [B](#F2){ref-type="fig"}), which is consistent with the proposed 'measure twice, cut once' mechanism ([@B45]). Several models for 5′ flap recognition by FENs have been proposed, and threaded 5′ flaps have been observed in both hFEN1- and T5FEN-DNA structures ([@B11],[@B46]). In our pre-threading structures, both the +1 and --1 bases of the 5′ flap remain base-paired to the template strand (Figure [2C](#F2){ref-type="fig"}). The unthreaded 5′ flap is engaged by the α2 helix and by the loop region before the α6 helix. Two residues, Tyr40 and Arg47, are important for arranging the gateway and form multiple interactions with the 5′-flap nucleotides. Overall nuclease activity of R47K mutant hFEN1 is greatly reduced, partly due to its reduced ability to form a cation-π stack with the 5′ nucleotide. Considering previous observations of the base-paired dsDNA in the active site of hFEN1 ([@B11]), our pre-threading structures suggest that the helical gateway, in addition to the cap helices, is also involved in 5′ flap recognition and the orientation of dsDNA into the active site.

Methylation of arginine side chains increases regional hydrophobicity ([@B47]). hFEN1 is symmetrically di-methylated at Arg192 and is recruited to the replication fork by PCNA in early S phase ([@B22]). hFEN1 methylation strongly inhibits its subsequent phosphorylation. Therefore, after cleavage, hFEN1 is demethylated prior to phosphorylation, which results in reduced FEN activity and dissociation from PCNA. To explore the possible molecular mechanisms by which methylation regulates hFEN1, we determined the crystal structures of R192F and D181A/R192F hFEN1 in complex with DNA. Although phenylalanine does not perfectly mimic the methylation of arginine, it increases hydrophobicity at the primary methylation site and has been used for studying the effects of arginine methylation by our and other groups ([@B22],[@B41],[@B42]). In both hFEN1--DNA structures, the β-pin region connecting β8 and β9 undergoes a loop-to-helix transition (Figure [3A](#F3){ref-type="fig"}), rendering these structures distinctly different from all other hFEN1 structures solved to date. The β-pin helix formation enhances interactions with surrounding hydrophobic residues, especially the aromatic His193 ([Supplementary Figure S5c](#sup1){ref-type="supplementary-material"}). Enhanced hydrophobic interactions due to arginine methylation have also been observed in the human histone/chromodomain structure ([@B48]) and the β-hairpin model system ([@B49]). Symmetrically di-methylated Arg192 was also modeled in our hFEN1--DNA structure ([Supplementary Figure S9](#sup1){ref-type="supplementary-material"}). The methylated arginine appears to be able to maintain hydrophobic interactions with surrounding residues, similarly to phenylalanine, with no obvious steric clash.

We proposed the following hFEN1 regulation mechanisms based on our hFEN1--DNA structures and *in vitro* biochemical studies. First, methylation at the Arg192 site might induce the conformational change of the β-pin region, which makes it more rigid. The β-pin maintains interactions with the upstream dsDNA (Figure [3B](#F3){ref-type="fig"}), and the FEN activity of hFEN1 is only slightly attenuated. However, this β-pin conformation could orient the η2 helix and residues at the hFEN1--PCNA interface (Figure [4A](#F4){ref-type="fig"}) to enhance recruitment to the DNA replication fork. Furthermore, our mutagenesis studies suggest that the β-pin region of the nuclease core is also involved in the direct protein--protein interactions of hFEN1. Alanine substitutions of two β-pin residues, Lys200 and Lys201, weakened the interactions of hFEN1 with WDR4 and Rad1, as well as with the protein kinases (Figure [4C](#F4){ref-type="fig"}). Moreover, these mutations could also destabilize the hFEN1--PCNA interface, leading to reduced PCNA binding. Second, after cleavage and JMJD1B-mediated demethylation, hFEN1 is typically phosphorylated ([@B50]). The phosphorylation site Ser187, however, is located close to the hFEN1--PCNA interface (Figure [4A](#F4){ref-type="fig"}). Therefore, the binding of PCNA, enhanced by hFEN1 methylation, may partially block the access of protein kinases to the phosphorylation site, which is consistent with the impaired interactions between R192F and the protein kinases CDK2 and Cyclin E, as well as the reduced phosphorylation level of R192F *in vivo* (Figure [4B](#F4){ref-type="fig"}). Third, in addition to its well-known FEN activity, hFEN1 possesses GEN and EXO activities. These distinct nuclease activities target different types of DNA substrates and must be tightly controlled. We observed that the R192F hFEN1 was defective for GEN activity but retained FEN activity (Figure [3C](#F3){ref-type="fig"}). These observations were reminiscent of the action of the E160D mutation in FEN1 ([@B43]). E160D selectively eliminates the GEN and EXO activities of FEN1, and heterozygous E160D mutation in mice results in the initiation and progression of cancers. In addition, WDR4 interactions with the FEN1/PCNA complex also suppress the GEN activity and promote the FEN activity for flap removal at the unstressed replication fork to maintain genome stability ([@B18]). Thus, methylation, as well as protein--protein interactions, might also control the balance between the FEN and GEN activities of hFEN1 to ensure accuracy during DNA replication.

We also observed that the cleavage of the GEN substrate by hFEN1 was less efficient than that of the FEN substrate ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}), which is probably due to the lack of a free 5′ flap. Although the detailed mechanisms of GEN cleavage by hFEN1 are poorly understood, the ssDNA region of gapped DNA is thought to roll into the active site for cleavage. In our pre-threading structures, the α2 helix contacts the ssDNA portion of the free 5′ end, and the R47K mutant protein with reduced 5′ interactions exhibited impaired GEN activity (Figure [3D](#F3){ref-type="fig"} and [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). These findings indicate that this protein-DNA interface is another important regulator of hFEN1 GEN cleavage.

Collectively, our results unveil several mechanisms by which hFEN1 activity is regulated (Figure [5](#F5){ref-type="fig"}). Methylation at the Arg192 site during DNA replication possibly induces the conformational change of the β-pin region of hFEN1 and enhances its PCNA binding and loading onto the DNA replication fork. During DNA replication, GEN activity of hFEN1 is suppressed by both methylation and partner proteins. For example, interaction with WDR4 ensures FEN activity for flap removal. Demethylation after cleavage is an essential step prior to phosphorylation, as both methylation and PCNA binding impair the interactions between hFEN1 and protein kinases. Additionally, the β-pin region in the nuclease core of hFEN1 participates in the recruitment of hFEN1 in response to DNA damage, which promotes both FEN and GEN activities.

![A model of methylation-based regulation of hFEN1. Upon methylation at the Arg192 site, the β-pin loop of hFEN1 is rigidified into a short helix. The loop-to-helix transition of the β-pin region ensures hFEN1 interactions with PCNA and WDR4 to remove the flapped DNA substrate. At this time both GEN activity and protein kinases interactions are suppressed. After demethylation, hFEN1 undergoes phosphorylation and possibly other types of posttranslational modifications. During DNA repair, the GEN activity of hFEN1 is stimulated by interactions with DNA repair proteins (e.g. the 9--1--1 complex).](gky911fig5){#F5}
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The coordinates and structure factors have been deposited to the Protein Data Bank with accession codes 5ZOD (wild-type apo-protein structure), 5ZOE (D181A hFEN1--DNA structure), 5ZOG (R192F hFEN1--DNA structure), and 5ZOF (D181A/R192F hFEN1--DNA structure).
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